Hello, my tipsy friends,
It’s been a booze-soaked week in biotech: J&J is making a multi-billion-dollar bet on sight loss (beer goggles excluded), investors have topped up Isomorphic Labs’ glass with $5B, a Viagra-like drug has given Alzheimer’s a stiff one, Moderna’s creator has brewed up its first AI lab outside the US, and one too many pints could wat…




